drugs Class II Updated 2012-12-05

Boehringer Ingelheim Roxane Inc recalls Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bot

Recalled Product

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54


Hazard / Issue

Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Lot 201900 Expiration Date: JAN 2015
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →